{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:59:09Z","timestamp":1777143549960,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Government of Nepal, Ministry of Health and population, Department of Health Services, Epidemiology and Disease Control Division."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. The World Health Organization (WHO) recommends G6PD screening before providing primaquine as a radical treatment against vivax malaria. However, evidence regarding the prevalence and causing mutations of G6PD deficiency in Nepal is scarce.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A cross-sectional, population-based, prevalence study was carried out from May to October 2016 in 12 malaria-endemic districts of Nepal. The screening survey included 4067 participants whose G6PD status was determined by G6PD Care Start\u2122 rapid diagnostic test and genotyping.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The prevalence of G6PD deficiency at the national level was 3.5% (4.1% among males and 2.1% among females). When analysed according to ethnic groups, G6PD deficiency was highest among the Janajati (6.2% overall, 17.6% in Mahatto, 7.7% in Chaudhary and 7.5% in Tharu) and low among Brahman and Chhetri (1.3%). District-wise, prevalence was highest in Banke (7.6%) and Chitwan (6.6%). Coimbra mutation (592 C&gt;T) was found among 75.5% of the G6PD-deficient samples analysed and Mahidol (487 G&gt;A) and Mediterranean (563 C&gt;T) mutations were found in equal proportions in the remaining 24.5%. There was no specific geographic or ethnic distribution for the three mutations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study has identified populations with moderate to high prevalence of G6PD deficiency which provides strong evidence supporting the WHO recommendations to screen G6PD deficiency at health facility level before the use of primaquine-based radical curative regimen for <jats:italic>Plasmodium vivax<\/jats:italic>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-03359-6","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T14:02:33Z","timestamp":1597240953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["G6PD deficiency in malaria endemic areas of Nepal"],"prefix":"10.1186","volume":"19","author":[{"given":"Baburam","family":"Marasini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibek Kumar","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran Raj","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijay","family":"Bajracharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shambhu Nath","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Iama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Kumar","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramin","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahachan Gharti","family":"Magar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan Kumar","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gornpan","family":"Gornsawun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimsupah","family":"Penpitchaporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4550-0431","authenticated-orcid":false,"given":"Germana","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhim Prasad","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"3359_CR1","volume-title":"World malaria report 2016","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2016. Geneva: World Health Organization; 2017."},{"key":"3359_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12936-017-1784-1","volume":"16","author":"K Thriemer","year":"2017","unstructured":"Thriemer K, Ley B, Bobogare A, Dysoley L, Alam MS, Pasaribu AP, et al. Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group. Malar J. 2017;16:141.","journal-title":"Malar J."},{"key":"3359_CR3","doi-asserted-by":"crossref","DOI":"10.18356\/3cff8bc0-en","volume-title":"The sustainable development goals report 2017","author":"United Nations","year":"2017","unstructured":"United Nations. The sustainable development goals report 2017. New York: United Nations; 2017."},{"key":"3359_CR4","volume-title":"Global technical strategy for malaria 2016\u20132030","author":"WHO","year":"2015","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015."},{"key":"3359_CR5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"3359_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2015.11.006","volume":"30","author":"L Luzzatto","year":"2016","unstructured":"Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 2016;30:373\u201393.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3359_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1871529X11313010008","volume":"13","author":"G Manganelli","year":"2013","unstructured":"Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord: Drug Targets. 2013;13:73\u201382.","journal-title":"Cardiovasc Hematol Disord: Drug Targets"},{"key":"3359_CR8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2875-13-70","volume":"13","author":"WM Monteiro","year":"2014","unstructured":"Monteiro WM, Franca GP, Melo GC, Queiroz AL, Brito M, Peixoto HM, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J. 2014;13:70.","journal-title":"Malar J."},{"key":"3359_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjh.12665","volume":"164","author":"L Luzzatto","year":"2014","unstructured":"Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164:469\u201380.","journal-title":"Br J Haematol"},{"key":"3359_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.011","volume":"161","author":"SR Marcsisin","year":"2016","unstructured":"Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art. Pharmacol Ther. 2016;161:1\u201310.","journal-title":"Pharmacol Ther"},{"key":"3359_CR11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J."},{"key":"3359_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133\u2013201.","journal-title":"Adv Parasitol"},{"key":"3359_CR13","doi-asserted-by":"crossref","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","volume":"14","author":"CS Chu","year":"2017","unstructured":"Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, et al. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens. PLoS Med. 2017;14:e1002224.","journal-title":"PLoS Med."},{"key":"3359_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","volume":"17","author":"CS Chu","year":"2018","unstructured":"Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. Malar J. 2018;17:101.","journal-title":"Malar J."},{"key":"3359_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1475-2875-12-112","volume":"12","author":"L von Seidlein","year":"2013","unstructured":"von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013;12:112.","journal-title":"Malar J."},{"key":"3359_CR16","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","journal-title":"PLoS Med."},{"key":"3359_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u201378.","journal-title":"Blood Cells Mol Dis"},{"key":"3359_CR18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1369\/jhc.2009.953828","volume":"57","author":"AL Peters","year":"2009","unstructured":"Peters AL, Van Noorden CJ. Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem. 2009;57:1003\u201311.","journal-title":"J Histochem Cytochem"},{"key":"3359_CR19","first-page":"CD004389","volume":"10","author":"GN Galappaththy","year":"2013","unstructured":"Galappaththy GN, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev. 2013;10:CD004389.","journal-title":"Cochrane Database Syst Rev"},{"key":"3359_CR20","first-page":"837","volume":"35","author":"J Chatterjea","year":"1966","unstructured":"Chatterjea J. Haemoglobinopathies, glucose-6-phosphate dehydrogenase deficiency and allied problems in the Indian subcontinent. Bull World Health Organ. 1966;35:837.","journal-title":"Bull World Health Organ"},{"key":"3359_CR21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0035-9203(87)90399-3","volume":"81","author":"A Henderson","year":"1987","unstructured":"Henderson A, Baronne A. Glucose-6-phosphate dehydrogenase deficiency in healthy Nepalese patients. Trans R Soc Trop Med Hyg. 1987;81:543.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3359_CR22","first-page":"390","volume":"48","author":"G Modiano","year":"1991","unstructured":"Modiano G, Morpurgo G, Terrenato L, Novelletto A, Di Rienzo A, Colombo B, et al. Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population. Am J Hum Genet. 1991;48:390\u20137.","journal-title":"Am J Hum Genet"},{"key":"3359_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10038-003-0018-2","volume":"48","author":"H Matsuoka","year":"2003","unstructured":"Matsuoka H, Jichun W, Hirai M, Yoshida S, Arai M, Ishii A, et al. Two cases of glucose-6-phophate dehydrogenase-deficient Nepalese belonging to the G6PD Mediterranean-type, not India-Pakistan sub-type but Mediterranean-Middle East sub-type. J Hum Genet. 2003;48:275\u20137.","journal-title":"J Hum Genet"},{"key":"3359_CR24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1179\/136485907X154539","volume":"101","author":"A Suzuki","year":"2007","unstructured":"Suzuki A, Hamano S, Shirakawa T, Watanabe K, Endo T, Sharma S, et al. The distribution of hereditary erythrocytic disorders associated with malaria, in a lowland area of Nepal: a micro-epidemiological study. Ann Trop Med Parasitol. 2007;101:113\u201322.","journal-title":"Ann Trop Med Parasitol"},{"key":"3359_CR25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12936-017-1864-2","volume":"16","author":"P Ghimire","year":"2017","unstructured":"Ghimire P, Singh N, Ortega L, Rijal KR, Adhikari B, Thakur GD, et al. Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal. Malar J. 2017;16:214.","journal-title":"Malar J."},{"key":"3359_CR26","volume-title":"Annual report 2015\/2016","author":"MoH","year":"2016","unstructured":"MoH. Annual report 2015\/2016. Kathmandu: Department of Health Services, Ministry of Health; 2016."},{"key":"3359_CR27","volume-title":"Nepal malaria strategic plan 2014\u20132025","author":"EDCD","year":"2014","unstructured":"EDCD. Nepal malaria strategic plan 2014\u20132025. Kathmandu: EDCD; 2014."},{"key":"3359_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41182-019-0148-7","volume":"47","author":"KR Rijal","year":"2019","unstructured":"Rijal KR, Adhikari B, Adhikari N, Dumre SP, Banjara MS, Shrestha UT, et al. Micro-stratification of malaria risk in Nepal: implications for malaria control and elimination. Trop Med Health. 2019;47:21.","journal-title":"Trop Med Health."},{"key":"3359_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1475-2875-13-241","volume":"13","author":"M Dhimal","year":"2014","unstructured":"Dhimal M, Ahrens B, Kuch U. Malaria control in Nepal 1963\u20132012: challenges on the path towards elimination. Malar J. 2014;13:241.","journal-title":"Malar J."},{"key":"3359_CR30","volume-title":"National malaria treatment protocol","author":"EDCD","year":"2015","unstructured":"EDCD. National malaria treatment protocol. Kathmandu: EDCD; 2015."},{"key":"3359_CR31","unstructured":"Nepal Health Sector Support Programme. Nepal Population Report 2011. http:\/\/www.nhssp.org.np\/NHSSP_Archives\/monitoring\/Nepal_Population_Report_2011.pdf."},{"key":"3359_CR32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12936-019-2652-y","volume":"18","author":"G Bancone","year":"2019","unstructured":"Bancone G, Menard D, Khim N, Kim S, Canier L, Nguong C, et al. Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion. Malar J. 2019;18:20.","journal-title":"Malar J."},{"key":"3359_CR33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10038-004-0187-7","volume":"49","author":"H Matsuoka","year":"2004","unstructured":"Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T, et al. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487 G>A) is the most common variant in the Myanmar population. J Hum Genet. 2004;49:544\u20137.","journal-title":"J Hum Genet"},{"key":"3359_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0039-1677729","volume":"8","author":"P Tripathi","year":"2019","unstructured":"Tripathi P, Agarwal S, Muthuswamy S. Prevalence and genetic characterization of glucose-6-phosphate dehydrogenase deficiency in anemic subjects from Uttar Pradesh, India. J Pediatr Genet. 2019;8:47\u201353.","journal-title":"J Pediatr Genet."},{"key":"3359_CR35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.meegid.2010.08.003","volume":"10","author":"S Sarkar","year":"2010","unstructured":"Sarkar S, Biswas NK, Dey B, Mukhopadhyay D, Majumder PP. A large, systematic molecular-genetic study of G6PD in Indian populations identifies a new non-synonymous variant and supports recent positive selection. Infect Genet Evol. 2010;10:1228\u201336.","journal-title":"Infect Genet Evol"},{"key":"3359_CR36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10038-007-0217-3","volume":"53","author":"I Nuchprayoon","year":"2008","unstructured":"Nuchprayoon I, Louicharoen C, Charoenvej W. Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar. J Hum Genet. 2008;53:48\u201354.","journal-title":"J Hum Genet"},{"key":"3359_CR37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004390100527","volume":"108","author":"K Iwai","year":"2001","unstructured":"Iwai K, Hirono A, Matsuoka H, Kawamoto F, Horie T, Lin K, et al. Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet. 2001;108:445\u20139.","journal-title":"Hum Genet"},{"key":"3359_CR38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2004.06.003","volume":"33","author":"S Sukumar","year":"2004","unstructured":"Sukumar S, Mukherjee MB, Colah RB, Mohanty D. Molecular basis of G6PD deficiency in India. Blood Cells Mol Dis. 2004;33:141\u20135.","journal-title":"Blood Cells Mol Dis"},{"key":"3359_CR39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02724295","volume":"71","author":"D Mohanty","year":"2004","unstructured":"Mohanty D, Mukherjee MB, Colah RB. Glucose-6-phosphate dehydrogenase deficiency in India. Indian J Pediatr. 2004;71:525\u20139.","journal-title":"Indian J Pediatr"},{"key":"3359_CR40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ejhg.2014.36","volume":"22","author":"G Chaubey","year":"2014","unstructured":"Chaubey G, Singh M, Crivellaro F, Tamang R, Nandan A, Singh K, et al. Unravelling the distinct strains of Tharu ancestry. Eur J Hum Genet. 2014;22:1404\u201312.","journal-title":"Eur J Hum Genet"},{"key":"3359_CR41","first-page":"139","volume":"6","author":"G Passarino","year":"1992","unstructured":"Passarino G, Semino O, Pepe G, Shrestha SL, Modiano G, Santachiara Benerecetti AS. MtDNA polymorphisms among Tharus of eastern Terai (Nepal). Gene Geogr. 1992;6:139\u201347.","journal-title":"Gene Geogr"},{"key":"3359_CR42","first-page":"CD010458","volume":"4","author":"S Rajapakse","year":"2015","unstructured":"Rajapakse S, Rodrigo C, Fernando SD. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2015;4:CD010458.","journal-title":"Cochrane Database Syst Rev"},{"key":"3359_CR43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-11-418","volume":"11","author":"NJ White","year":"2012","unstructured":"White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012;11:418.","journal-title":"Malar J."},{"key":"3359_CR44","volume-title":"Proposal for an Evidence Review Group (ERG) on G6PD testing to support increased access to primaquine for radical cure of Plasmodium vivax and for malaria chemoprophylaxis","author":"A Bosman","year":"2013","unstructured":"Bosman A, Cunningham J. Proposal for an Evidence Review Group (ERG) on G6PD testing to support increased access to primaquine for radical cure of Plasmodium vivax and for malaria chemoprophylaxis. Geneva: World Health Organization; 2013."},{"key":"3359_CR45","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"3359_CR46","volume-title":"Guidelines for case based investigation","author":"EDCD","year":"2017","unstructured":"EDCD. Guidelines for case based investigation. Kathmandu: EDCD, Government of Nepal; 2017."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03359-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03359-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:45:53Z","timestamp":1628725553000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03359-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3359"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03359-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Nepal Health Research Council (NHRC) with the (Reference number: 23\/2016). All study participants gave consent to participate in the study; they were provided with pre-test counseling and results of testing. Blood testing was conducted by qualified lab personnel.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}